Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Apr 20, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

Reply: To PMID 25154344

Atul Deodhar¹, Joachim Sieper, John D Reveille

¹Oregon Health & Science University, Portland, OR.

Arthritis & Rheumatology (Hoboken, N.J.)

|November 25, 2014

Summary

No abstract available in PubMed .

Related Experiment Videos

Last Updated: Apr 20, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bimekizumab Improves Health Status and Work Productivity, With Reduced Productivity Costs, to 3 Years in Axial Spondyloarthritis and Psoriatic Arthritis.

The Journal of rheumatology·2026

Same author

Bimekizumab Long-Term Safety and Efficacy Across the Spectrum of Axial Spondyloarthritis Over 3 Years: Results from Two Phase 3 Studies.

The Journal of rheumatology·2026

Same author

Bimekizumab treatment for sustained improvements in patient symptoms and health-related quality of life to 3 years in axial spondyloarthritis: results from the BE MOBILE studies and their open-label extension.

RMD open·2026

Same author

Axial spondyloarthritis: Moving beyond cytokine based therapies to cellular targets and advanced therapeutics.

Best practice & research. Clinical rheumatology·2026

Same author

Decoding pain in axial spondyloarthritis: Mechanisms, management, and future directions.

Best practice & research. Clinical rheumatology·2026

Same author

Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study.

The Journal of rheumatology·2026

Same journal

Deep Immunophenotyping Reveals Distinct Immune Signatures in Axial Spondyloarthritis and Psoriatic Arthritis.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Same journal

Same Family, Different Stories: Distinct Peripheral Immune Signatures in Axial Spondyloarthritis and Psoriatic Arthritis.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Same journal

ACR Treatment Guidelines and Expert Opinion: The Continuum of Knowledge Guiding Clinical Decision-Making.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Same journal

DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) mutations limit normal and autoreactive CD4+ T follicular helper responses and attenuate T cell-driven joint inflammation.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Same journal

Treatment of Patients with CPPD Disease: Where Do We Begin and Where Are We Going?

Arthritis & rheumatology (Hoboken, N.J.)·2026

Same journal

Efficacy and Safety of Nanoencapsulated Sirolimus plus Pegadricase: Results from the Randomized, Placebo-Controlled Phase 3 Trials.

Arthritis & rheumatology (Hoboken, N.J.)·2026

See all related articles